Connection

HASHEM EL-SERAG to Liver

This is a "connection" page, showing publications HASHEM EL-SERAG has written about Liver.
Connection Strength

0.316
  1. How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
    View in: PubMed
    Score: 0.090
  2. Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22; 365(12):1118-27.
    View in: PubMed
    Score: 0.057
  3. Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci. 2010 Jan; 55(1):190-5.
    View in: PubMed
    Score: 0.050
  4. Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol. 2005 Feb; 39(2):152-9.
    View in: PubMed
    Score: 0.036
  5. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul; 159(1):320-334.e27.
    View in: PubMed
    Score: 0.026
  6. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
    View in: PubMed
    Score: 0.026
  7. Carbamazepine-associated severe bile duct injury. Am J Gastroenterol. 1999 Feb; 94(2):526-7.
    View in: PubMed
    Score: 0.024
  8. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15; 138(8):627-33.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.